Ray Therapeutics, Inc. Company Profile, Contacts & Intelligence

Ray Therapeutics, Inc. Overview

Founded in 2021, Ray Therapeutics is a clinical-stage biotechnology company developing best-in-class vision restoration therapies for people with degenerative retinal diseases independent of genetic mutation. We use the innovative technology of optogenetics to reprogram surviving neurons in the retina of the eye to sense light and send visual signals to the brain—restoring vision. We are advancing our pipeline of optogenetic medicines to address a range of degenerative retinal diseases, with programs in both preclinical and clinical stages of development. Ray Therapeutics’ lead candidate, RTX-015, is bioengineered to repurpose retinal ganglion cells to restore vision, and is being evaluated in a Phase 1 trial in Retinitis Pigmentosa and Choroideremia.

Headquarters

2607 7th St

Website

www.raytherapeutics.com

Industry

Biotechnology Research

Founded

2021

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Ray Therapeutics, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Ray Therapeutics, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Ray Therapeutics, Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Ray Therapeutics, Inc.

Explore companies in related markets and compare their industry and employee estimates.